AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats [...]
Pfizer is halting investment in Russia but not ending its business there. Should drugmakers pull out altogether?
Pfizer is halting investment in Russia but not ending its [...]
Novartis puts contract manufacturing ambitions on display with deal to produce Carisma’s cell therapy
Novartis puts contract manufacturing ambitions on display with deal to [...]
With FDA AdComm on the books, Acadia sees glimmer of hope in second stab at Alzheimer’s psychosis
With FDA AdComm on the books, Acadia sees glimmer of [...]
J&J inks vaccine licensing deal with Aspen, paving the way for Africa’s first local COVID-19 shot
J&J inks vaccine licensing deal with Aspen, paving the way [...]
Lonza completes lab expansion at Chinese API production plant
Lonza completes lab expansion at Chinese API production plant jkeenan [...]
With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing
With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier [...]
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
Gilead Sciences will lay off 114 staffers based out of [...]
Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. with Teva’s generic launch
Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. [...]
Gilead drops unclear win for key Trodelvy breast cancer trial, poking holes in CEO’s oncology plan
Gilead drops unclear win for key Trodelvy breast cancer trial, [...]